Atherosclerosis is an inflammatory disease of the vessel wall characterized by monocyte infiltration in response to pro-atherogenic factors such as oxidized lipids. Recently, the role of specific adhesion molecules in this process has been explored. The endothelium overlying atherosclerotic lesions expresses P-selectin and the shoulder regions express vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), which is also expressed on endothelium in regions not prone to plaque development. Serum levels of soluble P-selectin, ICAM-1 and VCAM-1 are elevated in patients with angina pectoris or peripheral atherosclerotic disease. Reconstituted in vitro systems using monocytes on cytokine-activated endothelial cells under shear¯ow suggested the involvement of P-selectin, L-selectin, VCAM-1, its ligand, VLA-4 integrin and CD18 integrins. Studies of monocyte adhesion in isolated perfused carotid arteries harvested from atherosclerotic (apoE)/)) mice show a predominant involvement of P-selectin and its ligand P-selectin glycoprotein-1 (PSGL-1) in rolling and of VLA-4 and VCAM-1 in ®rm adhesion. Consistent with these ®ndings, apoE)/) mice that are also de®cient for P-selectin show signi®cantly reduced atherosclerotic lesion sizes and are almost completely protected from neointimal growth after vascular injury. Milder effects are also seen in the low-density lipoprotein (LDL) receptor de®cient (LDLR)/)) mouse. In a high cholesterol/ cholate model, a role of ICAM-1 and CD18 integrins was also shown, but this awaits con®rmation in more physiologic models. Transient blockade of the VLA-4/VCAM-1 adhesion pathway by antibodies or peptides in apoE)/) or LDLR)/) mice reduced monocyte and lipid accumulation in lesions. These data suggest that P-selectin, PSGL-1, VLA-4 and VCAM-1 are the most important adhesion molecules involved in monocyte recruitment to atherosclerotic lesions.
Atherosclerosis can be viewed as a specialized type of chronic in¯ammation (Ross 1999) . In response to atherogenic factors, mononuclear cells in blood attach, adhere and spread on the luminal surface of the arterial tree, particularly at branches and bifurcations (Glagov et al. 1988) . These cells migrate across the endothelium and accumulate within the intima. In the presence of oxidized low-density lipoprotein (ox-LDL), monocytes are converted to activated macrophages, take up lipoprotein particles and become foam cells (Faggiotto et al. 1984) . The formation of foam cells and their continued accumulation in the intima, accompanied by migration of smooth muscle cells from the media, lead to the ®rst stage of the atherosclerotic lesion, the fatty streak. Without removal of atherosclerotic factors, the fatty streak will progress to the second and third phases, ®brofatty and ®brous plaque, respectively, which are characterized by recruitment of more smooth muscle cells, proliferation of extracellular matrix components, and deposition of more intra-and extracellular lipid (Ross 1999) . The critical event precipitating a heart attack or an ischaemic stroke is plaque rupture. Unstable plaque prone to rupture is characterized by a thin ®brous cap, a high foam cell content, and expression of various matrix metalloproteinases (MMP). Plaque rupture is thought to be precipitated by active in¯amma-tion and mechanical plaque ®ssure along the shoulder regions of the lesion (Lee et al. 1996) .
INFLAMMATION AND ADHESION MOLECULES
During in¯ammation, a wide variety of cell±cell interactions are important, including leucocyte±leuco-cyte, leucocyte±endothelium, leucocyte±vascular smooth muscle cell, leucocyte±extracellular matrix and leucocyte±interstitial cell interactions. The proteins mediating these interactions, adhesion molecules, belong to four major families: (1) selectins, (2) selectin ligands, (3) integrins, (4) members of the immunoglobulin family (Harlan & Liu 1992 , Springer 1994 . A major function of these adhesion molecules is to promote leucocyte recruitment from the vasculature into tissue through a series of events, including leucocyte rolling along the endothelial cell surface, ®rm adhesion and activation, and extravasation into the tissue.
Leucocyte rolling is mediated mainly by the selectins and selectin ligands (Kansas 1996) . P-selectin is expressed on endothelial cells and platelets after stimulation, E-selectin is expressed on activated endothelium and L-selectin is constitutively expressed on the majority of leucocytes. These molecules are characterized by an N-terminal calcium-dependent lectin domain, an epidermal growth factor-like domain, a series of repeats with similarities to complement binding proteins, a transmembrane segment and a cytoplasmic region. P-selectin glycoprotein-1 (PSGL-1) has been described as a physiologically important selectin ligand. Other candidate selectin ligands have been proposed, but their pathophysiologic roles remain unclear. Blockade or knockout of one or more selectins or PSGL-1 signi®cantly affects leucocyte rolling and results in dramatic decreases in leucocyte adhesion and transmigration in in¯ammatory models (Kansas 1996) .
Leucocyte adhesion and transmigration are mediated by integrins and members of the immunoglobulin superfamily (Harlan & Liu 1992 , Springer 1994 . Integrins are heterodimeric molecules whose subfamilies are de®ned by a common b subunit non-covalently linked with various a subuits. The b 1 integrins (CD29) are also called very late antigens (VLA) because they are expressed on lymphocytes very late after activation. The leucocyte integrins share a b 2 (CD18) subunit. CD11a/ CD18 (a L b 2 , LFA-1) and CD11b/CD18 (a M b 2 , Mac-1) are members of this subfamily relevant to mononuclear cell traf®cking. The b 3 subfamily comprises the cytoadhesins, which include a IIb b 3 (GPIIb/IIIa) and a V b 3 , a vitronectin receptor. Some integrins have a primary binding site that recognizes a short peptide like arginine-glycine-aspartic acid (RGD), a tripeptide that exists in a number of extracellular matrix proteins (Springer 1990) . One of the integrins, a 4 b 1 (VLA-4), recognizes a motif containing the sequence glutamic acid-isoleucine-leucine-aspartic acid-valine-proline-seminethreomine (EILDVPST) within the alternatively spliced connecting segment (CS-1) region of ®bronectin, with the leucine-aspartic acid-valine (LDV) sequence being most critical (Komoriya et al. 1991) . Integrins are constitutively expressed on leucocytes, endothelial cells, as well as other cells and mediate both cell±cell and cell±matrix interactions.
The immunoglobulin superfamily members are type I transmembrane proteins characterized by a series of repeating extracellular IgG-like domains, a transmembrane region and a short cytoplasmic tail. Adhesion molecules in this family include intercellular adhesion molecules-1, 2, 3 (ICAM-1, 2 and 3), platelet endothelial cell adhesion molecule-1 (PECAM-1), and vascular cell adhesion molecule-1 (VCAM-1). The expression of VCAM-1 and ICAM-1 increases after stimulation of endothelium by in¯ammatory cytokines, while PECAM-1 is constitutively expressed on resting endothelial cells. VCAM-1 is an important endothelial ligand for VLA-4. ICAM-1, -2 and -3 bind to a L b 2 integrin (LFA-1), and ICAM-1 and -2 also bind to a M b 2 (Mac-1). PECAM-1 engages in homotypic adhesion to PECAM-1 molecules on other cells and may also bind to a V b 3 integrin. Blockade or loss of one or more of the members of the immunoglobulin superfamily will decrease leucocyte adhesion and extravasation and in some cases, also affect leucocyte rolling.
ADHESION MOLECULES AS RISK FACTORS FOR ATHEROSCLEROSIS
Expression of several adhesion molecules was found on established atherosclerotic lesions (Table 1 ). In human atherosclerotic lesions, strong expression of P-selectin was detected on the endothelium overlying active atherosclerotic plaques but not on normal arterial endothelium or on endothelium overlying inactive ®brous plaques (Johnson-Tidey et al. 1994) . Spotty E-selectin expression was con®ned to endothelial cells and occurred on the surface of ®brous and lipidcontaining plaques (Davies et al. 1993) . However, E-selectin expression was not con®rmed by other investigators (Iiyama et al. 1999) . The expression of ICAM-1 was detected on endothelial cells, macrophages and smooth muscle cells of plaques with an increase after vascular injury (Manka et al. 1999) . Normal arterial endothelial cells and intimal smooth muscle cells outside plaques gave weaker or negative reactions (Poston et al. 1992 , Johnson-Tidey et al. 1994 . Unlike E-selectin and ICAM-1, VCAM-1 staining of surface endothelium only occurred in ®brous and lipid-containing plaques (O'Brien et al. 1993) . In addition, subsets of plaque smooth muscle cells and macrophages also express VCAM-1 (Davies et al. 1993 , O'Brien et al. 1993 , and this expression is vastly increased after injury (Manka et al. 1999) .
Based on this pro®le of expression of adhesion molecules, the response-to-injury hypothesis of atherosclerosis was proposed, a theory that supposes the recruitment of mononuclear cells from the luminal surface of arteries (Ross 1999) . However, in human coronary atherosclerotic plaques, expression of E-selectin, ICAM-1 and VCAM-1 on plaque neovasculature was twofold higher than on arterial luminal endothelium. Increased plaque intimal macrophage density was associated with expression of VCAM-1 on neovasculature and on non-endothelial cells. Increased plaque intimal T-lymphocyte density was associated with the presence of both ICAM-1 and VCAM-1 on neovasculature and on non-endothelial cells, suggesting that leucocyte recruitment through and/or activation of intimal neovasculature may participate in the pathogenesis of human atherosclerosis (O'Brien et al. 1996) . However, the role of neomicrovessels in in¯ammatory cell recruitment to plaque remains unclear.
Expression of adhesion molecules was also detected on established lesions in animal models of atherosclerosis. Hypercholesterolaemia induced atherosclerotic lesion formation in rabbits, LDL-receptor-de®cient (LDLR)/)) and apolipoprotein E-de®cient (apoE)/)) mice. Immunohistochemical staining revealed that VCAM-1 and ICAM-1 were expressed predominantly by endothelium in early lesions and by intimal cells in more advanced lesions. Staining was most intense in endothelial cells at and adjacent to lesion borders (Nakashima et al. 1998 , Iiyama et al. 1999 .
Expression of adhesion molecules on established atherosclerotic lesions may be a cause or a consequence of mononuclear cell recruitment. To distinguish between these possibilities, adhesion molecule expression was investigated on endothelium prone to develop atherosclerotic lesions preceding mononuclear in®ltra-tion. In the arterial endothelium during the early phases of diet-induced atherogenesis in rabbits in vivo, the endothelium in the ascending aorta or in lesion-prone areas focally expressed P-selectin and VCAM-1 after only 1 week on the atherogenic diet and before the ®rst appearance of intimal macrophages (Li et al. 1993 , Sakai et al. 1997 . In aortas of normal chow-fed wild-type mice and rabbits, VCAM-1 and ICAM-1, but not E-selectin, PECAM-1 Aortas of apoE)/) mice with cholesterolaemia Expression localized at the cell periphery throughout the aorta, no relation to lesion, not regulated (Nakashima et al. 1998) Fibronectin Human arteries with atherosclerotic lesions Expression of FN on luminal surface but no VCAM-1 expression (Shih et al. 1999a, b) were expressed by endothelial cells in regions predisposed to atherosclerotic lesion formation. En face confocal microscopy of the mouse ascending aorta and proximal arch demonstrated that VCAM-1 expression was increased on the endothelial cell surface in lesionprone areas. By contrast ICAM-1 expression extended into areas protected from lesion formation (Iiyama et al. 1999) . When mice were fed a western diet to cause hypercholesterolaemia, VCAM-1 appeared to be localized on groups of endothelial cells in lesion-prone sites in apoE)/) mice, but not control mice. Although ICAM-1 was the most prominent adhesion molecule in lesion-prone sites, its expression was not highly connected to lesion-prone sites in either apoE)/) mice or control mice. The PECAM-1 was localized at the cell periphery throughout the aorta, and its expression did not appear to be regulated (Nakashima et al. 1998) . Atherosclerotic risk factors can regulate the expression of adhesion molecules on endothelial cells in culture, suggesting there may be a cause-and-effect relationship between expression of adhesion molecules and atherogenesis. Hypercholesterolaemia is an important determinant of lesion formation, and LDL, in particular, is a signi®cant atherogenic stimulus. Modi®cations to LDL (oxidized LDL, oxLDL, or minimally modi®ed LDL, MM-LDL) make it more atherogenic than native LDL (Steinberg 1997) . The LDL interactions with the endothelium induce VCAM-1 expression in human coronary artery (HCAEC) and pig aortic endothelial cells (PAEC) and VCAM-1 and E-selectin expression in human aortic endothelial cells (HAEC) (Allen et al. 1998) . Treatment of HAECs with MM-LDL for 24 h caused a two to threefold increase of P-selectin protein, with little change in P-selectin surface expression. A 15-min histamine treatment of cells exposed to MM-LDL caused a 50±100% increase in P-selectin surface expression compared with cells not treated with the lipoprotein (Vora et al. 1997) . Dose± response and time course studies demonstrated that oxLDL enhanced VCAM-1 expression induced by TNF-a by 63% in HAECs and by 45% in human umbilical vein endothelial cells (HUVECs) over unmodi®ed LDL or control. OxLDL augmented TNFa -induced ICAM-1 expression by 44% in HAECs. Similar results were obtained with 13-HPODE or lysophosphatidylcholine, signi®cant components of oxLDL. These studies suggest that as long-term regulatory signals, speci®c oxidized fatty acid and phospholipid components of oxLDL augment the ability of vascular endothelial cells to express adhesion molecules (Khan et al. 1995) .
Shear stress is another atherosclerotic risk factor; its crucial role in atherogenesis is suggested by the fact that lesions are ®rst and mainly located on the bifurcations and branches of arteries. Low and oscillatory shear stresses are major features of the haemodynamic environment of sites opposite arterial¯ow dividers that are predisposed to atherosclerosis (Glagov et al. 1988) . Prolonged oscillatory shear stress up-regulated expression of VCAM-1 on average ninefold relative to endothelial monolayers in static culture. ICAM-1 and E-selectin exhibited 11-and 7.5-fold increases, respectively (Chappell et al. 1998) . Laminar¯ow induced a signi®cant increase in the surface expression of ICAM-1 (Morigi et al. 1995) , while it down-regulated the expression of VCAM-1 on the endothelium (Ando et al. 1995) . In rabbit carotid arteries in which shear stress had been changed by surgical manipulations, en face immuno¯uorescence revealed that VCAM-1 expression was greatly increased under low shear stress. Monocytes adhered to endothelium under low shear stress; 65% of the monocytes colocalized with detectable VCAM-1 (Walpola et al. 1995) . VCAM-1 expression increased to a lesser extent when shear stress was approximately doubled. ICAM-1 was detected even at normal shear stresses (Walpola et al. 1995) . Other risk factors for atherosclerosis like hypertension (Mervaala et al. 1999) , diabetes mellitus (Vlassara et al. 1995) and smoking (Shen et al. 1996) can also increase expression of adhesion molecules on endothelium and may have synergistic effects.
Endothelial and leucocyte adhesion molecules also exist as soluble molecules in the plasma, mainly generated by proteolytic cleavage or alternative splicing. The serum level of P-selectin, ICAM-1 and VCAM-1 is strongly associated with angina (Ghaisas et al. 1997) , myocardial infarction (Kaikita et al. 1997) or the extent of atherosclerotic disease as measured by angiography (Saku et al. 1999 ).
INVOLVEMENT OF ADHESION MOLECULES IN MONONUCLEAR CELL/ ENDOTHELIAL CELL INTERACTIONS AND IN ATHEROGENESIS
The expression pattern of adhesion molecules in space and time suggests a possible cause±effect relationship between expression of adhesion molecules, mononuclear cell/endothelium interaction and atherogenesis. Various studies have been carried out to test the hypothesis that expression of adhesion molecules and mononuclear cell adhesion may be important for mononuclear cell/endothelium interaction and for atherosclerotic lesion formation.
In an in vitro¯ow model system, freely¯owing monocytes initially attached on TNF-a-activated HUVEC under¯ow via L-and P-selectin, whereas E-selectin was not involved . VLA-4 did not support monocyte initial attachment. Once initially attached, a small number of monocytes began rolling through a mechanism involving L-selectin, as well as VLA-4 and Mac-1 integrins, while the remaining monocytes became ®rmly adherent, or detached. Monocyte stable arrest and subsequent transendothelial migration occurred rapidly and ef®ciently through either VLA-4 or CD18 integrin adhesion pathways. It was necessary to block both VLA-4 and CD18 to block adhesion and transmigration. Transendothelial passage was also dependent on PECAM-1 . In a similar system on IL-4-activated human umbilical vein endothelium, which selectively expresses VCAM-1 and an L-selectin ligand, but not E-selectin, L-selectin mediated monocyte rolling and also facilitated VLA-4 integrin-dependent arrest, whereas b 2 -integrins were required for spreading of ®rmly attached monocytes on the endothelial cell surface but not their arrest (Luscinskas et al. 1994) .
Treatment of HAECs with MM-LDL induces monocyte binding. This monocyte binding was not mediated by endothelial E-selectin, P-selectin, VCAM-1, or ICAM-1. Monocytic VLA-4 integrin and CS-1 domain of FN induced on the apical surface of HAEC by MM-LDL contribute to the interaction of monocytes with endothelium (Shih et al. 1999a, b) . Transfecting the resting endothelium with adenovirus carrying VCAM-1, Gerszten et al. showed that VCAM-1 alone on the endothelium supported lymphocyte adhesion but not rolling and transmigration, while it was able to mediate monocyte rolling, ®rm adhesion and transmigration (Gerszten et al. 1996 (Gerszten et al. , 1998 . These studies suggested that VCAM-1 might have a crucial role in mediating monocyte recruitment. However, more ef®cient binding of mononuclear cells to endothelium required activation of integrins by chemokines (Gerszten et al. 1999 , Weber et al. 1999 .
The above in vitro studies about roles of adhesion molecules in monocyte interaction with endothelium use endothelial cells cultured under various conditions that can only incompletely mimic the pathophysiological process of endothelial activation in atherosclerosis in vivo. To investigate the function of adhesion molecules in a model directly relevant to monocyte interaction with endothelium in atherogenesis, our lab developed a novel ex vivo model. Feeding apoE)/) mice with western diet for 5 weeks, the common carotid arteries developed atherosclerosis. We found expression of VCAM-1, ICAM-1, and P-selectin on the endothelium near the carotid bifurcation prior to monocyte in®l-tration of the intima (Ramos et al. 1999 , Huo et al. 2000 . Carotid arteries from apoE)/) mice were cannulated, perfused and mounted on an intravital microscope stage. Using continuous perfusion at 10±20 lL min ±1 with physiological salt solution containing¯uorescently labelled mononuclear cells, cell rolling and adhesion can be observed with stroboscopic epi¯uorescence video microscopy. Wall shear stress is about 3.0 dyn cm ±2 and perfusion pressure is about 40±60 mmHg in this model. Monocyte rolling and attachment are nearly abrogated by blocking P-selectin or PSGL-1 (Ramos et al. 1999) . Consequently, monocyte accumulation and adhesion on the early atherosclerotic endothelium were also dramatically inhibited (Huo et al. 2000) . Effects of L-selectin on monocyte rolling and adhesion were not found in this model. Monocyte adhesion was reduced 95% by blockade of VLA-4. Blocking interaction of VLA-4 with FN decreased adhesion by only 30%. In contrast, blocking VCAM-1 on endothelium with antibody or treating monocytes with CS-1 peptide (EILDVPST) reduced adhesion by 75 or 68%, respectively. When VLA-4 or VCAM-1 was blocked, more mononuclear cells rolled on early lesions at signi®cantly higher (approximately doubled) rolling velocities (Ramos et al. 1999 , Huo et al. 2000 .
To investigate involvement of adhesion molecules and the monocyte/endothelial interaction mediated by these adhesion molecules in the formation of atherosclerotic lesions, studies on lesion formation in vivo have been performed on atherosclerotic animal models using blocking antibodies or adhesion molecule knockout mice (Table 2) . These results indicate what role each speci®c molecule plays in the formation of lesion, but in most cases, only an end point (lesion size) can be observed.
Using C57BL/6 mice fed a high fat, high cholesterol diet, Nageh et al. (1997) observed a 63% reduction in atherosclerotic fatty streaks in mice with a null mutation for P-selectin. LDLR)/) mice develop atherosclerotic lesions similar to those found in humans. When P-selectin±/± mice were intercrossed with LDLR)/) mice and fed an atherogenic diet rich in saturated fat and cholesterol, P-selectin±/± mice on diet for 8±20 weeks formed signi®cantly smaller fatty streaks in the cusp region of the aortae than control mice. This difference was only observed in males. At 37 weeks on diet, the lesions in the LDLR)/) mice progressed to the ®brous plaque stage and were distributed throughout the entire aorta; their size or distribution was no longer dependent on P-selectin (Johnson et al. 1997) . The P-selectin±/± mice were also intercrossed with apoE)/) mice. At 4 months of age on regular chow diet, apoE)/) P-selectin±/± mice had 3.5-fold smaller aortic sinus lesions than apoE)/) mice with intact P-selectin. These were limited to fatty streaks in the apoE)/) P-selectin±/± mice, whereas 70% of control lesions contained smooth muscle cells (Dong et al. 2000) . Signi®cantly, more of the aortic sinus circumference was covered by lesions in the control animals. The P-selectin genotype affected macrophage recruitment, because twice as many mononuclear cells were present in the P-selectin-positive lesions. At 15 months, the lesion progressed to the ®brous plaque stage in both genotypes and spread throughout the aorta, but this process was delayed in apoE)/) Pselectin±/± mice. In the aortic sinus, the lesions of the apoE)/) P-selectin±/± mice were 2.6-fold smaller and less calci®ed (Dong et al. 2000) . Collins et al. (2000) studied the lesion formation in apoE)/) P-selectin±/± mice and apoE)/)E-selectin±/± mice at 20 weeks of age fed a regular chow diet. Lesion area observed in P-selectin±/± mice was reduced by 40% in males, 49% in females. Therefore, P-selectin appears to be a key adhesion receptor mediating leucocyte recruitment into lesions and promoting advanced atherosclerosis in apoE)/) mice. Lesion area was also reduced in E-selectin/apoE)/) mice by 25% in males and by 26% in females (Collins et al. 2000) . A combined effect of these selectins on the development of atherosclerotic lesions was suggested by studies in P-and E-selectindouble-de®cient mice (P/E)/) mice) bred onto the LDLR)/) background (LDLR)/) P/E)/)). After 8 weeks on atherogenic diet, the LDLR)/) P/E)/) mice developed fatty streaks in the aortic sinus that were ®ve times smaller than those in LDLR)/) P/E+/+mice. The density of macrophages in the fatty streaks was comparable between LDLR)/) P/E+/+ Lesions in the cusp smaller in P-selectin±/± males at 8 and 20 week of diet in males, no difference in female, no difference at 37 weeks (Johnson et al. 1997 ) apoE)/) mouse; chow 4 or 15 months Aortic sinus lesions reduced by 72% at 4 months, macrophage in®ltration reduced by 50% in P-selectin±/± mice. At 15 months, aortic sinus lesion reduced by 62% (Dong et al. 2000 ) apoE)/) mouse; chow 20 weeks Aortic lesion size in aortas reduced by 40±50% in P-selectin±/± mice (Collins et al. 2000 ) apoE)/) mouse; western diet and isolated Rolling and adherent monocytes reduced over carotid arteries 80% by P-selectin mAb (Ramos et al. 1999) E-selectin apoE)/) mouse; chow 20 weeks Aortic lesion size reduced by 25±26% in E-selectin±/± mice (Collins et al. 2000) P-, E-selectin LDLR)/) mouse; high fat, high cholesterol Aortic lesion size decreased by 80% in P/E-selectin±/± mice at 8 weeks, after 37 week diet, by 37% and less calci®cation (Dong et al. 1998) ICAM-1 C57BL/6 mouse; high-fat, high cholesterol Aortic lesion size decreased by 63% in ICAM-1±/± mice at 20 weeks (Nageh et al. 1997) apoE)/) mouse; chow for 20 weeks Aortic lesion size reduced by 31% in ICAM-1±/± mice (Collins et al. 2000 ) apoE)/) mouse; western diet for 40 weeks
Peritoneal macrophage homing to lesions reduced by 65% by ICAM-1 mAb (Patel et al. 1998) CD18 C57BL/6 mouse; high-fat, high-cholesterol Aortic lesion size decreased by 47% in CD18±/± (hypomorph) mice (Nageh et al. 1997) .
ICAM-1, C57BL/6 mouse; high-fat, high-cholesterol Aortic lesion size decreased by 76% in CD18/ICAM-1±/± mice at 20 weeks CD18 (Nageh et al. 1997) VCAM-1 apoE)/) mouse; western diet and isolated Adherent monocytes reduced 75% by mAb (Huo et al. 2000) ; rolling carotid arteries velocities doubled after VCAM-1 mAb (Ramos et al. 1999 ) LDLR)/) mouse; high fat Aortic arch lesion reduced by 38% in VCAM-1 hypomorphic mutant, whole aorta lesion reduced by 48%, no effect of ICAM-1)/) (Cybulsky et al. 2001 ) VLA-4 C57BL/6 mouse; high fat, high-cholesterol FN CS-1 peptide reduced lesion size in aortic sinus by 68%, leucocyte in®ltration reduced 48%, lipid accumulation reduced 67% (Shih et al. 1999a , b) LDLR)/) mouse; high fat, high-cholesterol Lipid accumulation in the aortic sinus reduced by 66% (Shih et al. 1999a , b) apoE)/) mouse; western diet and isolated Adherent monocytes reduced >90% by VLA-4 mAb (Huo et al. 2000) ; carotid arteries rolling velocities doubled after VLA-4 mAb (Ramos et al. 2000 ) apoE)/) mouse; western diet for 40 weeks Peritoneal macrophages homing to lesions reduced 75% by VLA-4 mAb (Patel et al. 1998) and LDLR)/) P/E)/) mice. After 22 weeks on the diet, the lesions spread throughout the aorta, but this process was delayed in LDLR)/) P/E)/) mice. At 37-week on diet, the lesions progressed to the ®brous plaque stage in both genotypes, the lesions in the aortic sinus in LDLR)/) P/E)/) mice were 40% smaller and less calci®ed than those of LDLR)/) P/E+/+ mice (Dong et al. 1998) . However, these studies are dif®cult to interpret because PE)/) mice have grossly abnormal hematopoiesis, highly elevated white blood cell counts and spontaneous pathology (Bullard et al. 1996) . Patel et al. injected mouse peritoneal macrophages loaded with¯uorescent microspheres intravenously into 40-week-old apoE)/) mice. After 48 h, labeled macrophages were observed adhering to all stages of atherosclerotic plaques from the early fatty streak to mature calci®ed lesions. Pre-treatment of the apoE)/) mice with monoclonal antibodies directed against ICAM-1 reduced macrophage homing by 65% compared with isotype-matched controls (Patel et al. 1998) . Studies on lesion formation were also performed on female mice lacking functional ICAM-1, CD18 or both. After a high-fat, high-cholesterol diet for 20 weeks, aortic lesion size was reduced by 63% in ICAM-1±/± mice, by 47% in CD18±/± mice and by 76% in ICAM-1/CD18±/±mice (Nageh et al. 1997) . Crossing ICAM-1±/± mice with apoE)/) mice, Collins et al. quanti®ed the effect of ICAM-1 on atherosclerotic lesion formation at 20 week of age on a normal chow diet. The ICAM-1±/± mice had signi®cantly less lesion area than their ICAM-1+/+ littermates, the lesion size decreased by 31%. The reduction in lesion area was less than that in P-selectin/apoE)/) mice but more than that in E-selectin/apoE)/) mice.
As a bridging molecule, ®brinogen can mediate leucocyte interaction with endothelium through binding a M b 2 on the leucocyte and ICAM-1 on the endothelium (Languino et al. 1993) . To directly examine the role of ®brin(ogen) in atherogenesis, Xiao et al. (1998) crossed Fibrinogen-de®cient mice (Fib±/±) to apoE)/) mice. They found that both apoE)/) and apoE/Fib±/± mice developed lesions throughout the entire aortic tree, ranging in appearance from simple fatty streaks to complex ®brous plaques. Furthermore, remarkably little difference in lesion size and complexity was observed within the aortas of age-and gender-matched apoE)/) and apoE/Fib±/± mice. These results indicate that the contribution of ®brin(ogen) to intimal mass and local cell adhesion, migration and proliferation is not strictly required for the development of advanced atherosclerotic disease in mice with a severe defect in lipid metabolism.
In the isolated-perfused carotid artery model, monocytes adhere to early atherosclerotic endothelium mainly through a 4 b 1 (VLA-4) binding its endothelial ligands VCAM-1 and FN (Huo et al. 2000) . Geneknockout experiments showing the importance of a 4 integrins, VCAM-1 and FN for atherosclerotic lesion development have been hampered by the unavailability of these mice. Null mutations for VCAM-1 (Gurtner et al. 1995) , a 4 (Arroyo et al. 1996) and FN (George et al. 1997) , all lead to embryonic lethality so that no adult mice are available to study the impact of these molecules on atherosclerosis. However, the crucial roles of these molecules in atherosclerosis in vivo still can be demonstrated by peptide or antibody blocking experiments. Pretreatment of apoE)/) mice with a 4 integrin antibody reduced peritoneal macrophage homing atherosclerotic lesions by 75%, while an ICAM-1 antibody reduced it by 65% (Patel et al. 1998) . Soluble FN CS-1 peptide interacts the VLA-4 to block binding of FN and VCAM-1. Recruitment of leucocytes in the aortic sinus of C57BL/6 mice was inhibited by 48% by chronically infusing CS-1 peptide for 24± 36 h before the onset of the atherogenic diet and maintaining infusion for 4 weeks. Mice that received CS-1 peptide also demonstrated signi®cantly reduced lesion areas (by 68%) as compared with mice that received control peptide. In a separate study, using frozen sections stained with Oil Red O to assess lipid accumulation in the aortic sinus, LDLR)/) mice receiving CS-1 peptide showed a signi®cantly reduced area of lipid accumulation in the aortic sinus, resulting in an approximate 66% decrease. This study provides in vivo evidence that the VLA-4 integrin plays an important role in the initiation of the atherosclerotic lesion and lipid accumulation (Shih et al. 1999a, b) . The important role of VCAM-1 as a ligand for VLA-4 was recently established in VCAM-1 hypomorphic mice showing 48% reduction in aortic lesion site on the LDLR)/) background (Cybulsky et al. 2001) .
CONCLUSION
In vitro and animal studies suggest that P-selectin, PSGL-1, VLA-4 and VCAM-1 are the most important adhesion molecules in recruiting monocytes to atherosclerotic lesions. These results are supported by epidemiological evidence correlating the level of soluble adhesion molecules in serum with atherosclerotic disease. Some, but not all models suggest a role for E-selectin, ICAM-1 and b 2 integrin. Taken together, the data provide strong evidence that adhesion molecules are central to monocyte recruitment, the initiation and progression of atherosclerotic disease. Novel therapeutic approaches aimed at curbing the expression or function of adhesion molecules may prove bene®cial in the management and prevention of atherosclerosis.
